Skip to content
Toll-Free: 0800 CORDBANK Questions? Request more information here.

Cord Blood Trial to help Premature and Low Birth-weight Babies

Doctors at the Ain Shams University Medical School in Cairo have registered a clinical trial with the United States National Institute of Health that aims to infuse premature and low birth-weight (less than 3.3 pounds) newborn infants with their own cord blood to speed up lung development and therefore reliance on respiratory machinery in neonatal…

Read More

Cord Blood Aids Diabetic Wound Healing

Diabetics are naturally prone to a large array of complications and infections, most of which are worsened by their inability to heal well. But transplanting cord blood-derived endothelial progenitor cells (EPCs) has been found to “significantly accelerate” wound closure in diabetic mice, says a team of Korean researchers. EPCs are rare cells that circulate in…

Read More

Clinical Trial Looks to bring Cord Blood Treatment for Cerebral Palsy Closer to Home

A clinical trial currently awaiting approval will mean that children suffering from cerebral palsy like Zac and Maia won’t have to travel to the United States for treatment with their own cord blood. As reported in The Sydney Morning Herald, researchers at Melbourne’s Monash Medical Centre are currently awaiting approval to start a clinical trial…

Read More

First Australian Child Receives Cord Blood Treatment at Duke University

When 5 year old Australian child, Zac Archer suffered a stroke at 4 months of age, he was left with profound cerebral palsy and epilepsy. In a twist of fate, Zac’s mum Gabrielle had donated his cord blood to a public blood bank in Australia. Remarkably, it was still in storage when they discovered the…

Read More

Cord Blood Cells Show Promise for Alzheimer’s Patients

Researchers from the University of South Florida and their private sector collaborators say transplanting stem cells derived from umbilical cord blood may offer future therapeutic benefit for those suffering the degenerative and ultimately fatal Alzheimer’s disease, which affects around 43,000 New Zealanders. Those figures are projected to double in the next 15 years, and to…

Read More

Dr Wise Young speaks about Spinal Injury & Cord Blood

Eminent neuroscientist Dr Wise Young delivered hope to practitioners and patients alike during his visit to New Zealand recently to raise awareness regarding his clinical trials treating spinal cord injury. Young is the founding director of the W M Keck Center for Collaborative Neuroscience and a professor at Rutgers, the State University of New Jersey.…

Read More
Call Now Button